Viracta Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Viracta Therapeutics, Inc.
CIK #0001061027, 0001416377
EDGAR Form CIK 2011 - 2025
10-K [0001061027]
10-Q [0001061027]
3 [0001061027]
4 [0001061027]
8-K [0001061027]
SC 13D [0001061027]
SC 13G [0001061027]
D [0001416377]
SC 13D [0001416377]
SC 13G [0001416377]
Form 13D/13G Filer Form 13D/13G Subject Filed
Forward Ventures V LP Viracta Therapeutics Inc [2025-02-14]
Forward Ventures V LP Viracta Therapeutics Inc [2024-02-13]
BlackRock Inc Viracta Therapeutics Inc [2022-07-08]
Aisling Capital IV LP Viracta Therapeutics Inc [2022-02-14]
BlackRock Inc Viracta Therapeutics Inc [2022-02-04]
Forward Ventures V LP Viracta Therapeutics Inc [2021-03-08]
LVP Life Science Ventures III LP Viracta Therapeutics Inc [2021-03-04]
Schindel Yair Chaim Sunesis Pharmaceuticals Inc [2021-03-02]
Schindel Yair Chaim Viracta Therapeutics Inc [2021-03-01]
Lytton Laurence W Sunesis Pharmaceuticals Inc [2021-01-04]
Ayrton Capital LLC Sunesis Pharmaceuticals Inc [2020-08-07]
CVI Investments Inc Sunesis Pharmaceuticals Inc [2020-08-03]
Sabby Management LLC Sunesis Pharmaceuticals Inc [2020-07-29]
Avidity Partners Management LP Sunesis Pharmaceuticals Inc [2020-03-12]
Samsara Biocapital LP Sunesis Pharmaceuticals Inc [2020-03-05]
Nantahala Capital Management LLC Sunesis Pharmaceuticals Inc [2020-02-14]
RTW Investments LP Sunesis Pharmaceuticals Inc [2019-07-22]
Caxton Corp Sunesis Pharmaceuticals Inc [2019-07-19]
Armistice Capital LLC Sunesis Pharmaceuticals Inc [2019-01-28]
JFL Capital Management LLC Sunesis Pharmaceuticals Inc [2019-01-25]
Boxer Capital LLC Sunesis Pharmaceuticals Inc [2018-03-05]
Eventide Asset Management LLC Sunesis Pharmaceuticals Inc [2018-02-12]
RA Capital Management LLC Sunesis Pharmaceuticals Inc [2017-11-13]
MPM Oncology Impact Management GP LLC Sunesis Pharmaceuticals Inc [2017-11-06]
Balyasny Asset Management LLC Sunesis Pharmaceuticals Inc [2017-07-05]
DAFNA Capital Management LLC Sunesis Pharmaceuticals Inc [2017-02-14]
Aisling Capital IV LP Sunesis Pharmaceuticals Inc [2017-01-06]
Cormorant Asset Management LLC Sunesis Pharmaceuticals Inc [2016-10-31]
Palo Alto Investors LLC Sunesis Pharmaceuticals Inc [2016-02-16]
Great Point Partners LLC Sunesis Pharmaceuticals Inc [2015-12-28]
Baker Bros Advisors LP Sunesis Pharmaceuticals Inc [2015-02-17]
Alta Biopharma Partners III LP Sunesis Pharmaceuticals Inc [2015-02-12]
Biotechnology Value Fund L P Sunesis Pharmaceuticals Inc [2014-11-14]
Citadel Advisors LLC Sunesis Pharmaceuticals Inc [2014-09-22]
Price T Rowe Associates Inc /MD/ Sunesis Pharmaceuticals Inc [2014-02-13]
Alta Biopharma Partners III LP Sunesis Pharmaceuticals Inc [2014-01-14]
FMR LLC Sunesis Pharmaceuticals Inc [2013-03-11]
BlackRock Inc Sunesis Pharmaceuticals Inc [2013-01-30]
RA Capital Management LLC Sunesis Pharmaceuticals Inc [2012-09-26]
Visium Asset Management LP Sunesis Pharmaceuticals Inc [2012-09-21]
Form 3/4/5 Subject 2011 - 2025
Royston IVOR
Viracta Therapeutics, Inc.
Pomerantz Roger
Rubino Stephen
Darcy Thomas E
Simon Barry J.
Barlow Jane F
Borellini Flavia
Chung Jane
Murphy Samuel Lafayette
View All
Terms | Privacy | Guide
tony@aum13f.com